Collegium Pharmaceutical (COLL)
(Delayed Data from NSDQ)
$34.25 USD
+0.43 (1.27%)
Updated May 24, 2024 04:00 PM ET
After-Market: $34.26 +0.01 (0.03%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth B Momentum A VGM
Earnings News For COLL
-
Collegium Pharmaceutical (COLL) Q1 Earnings and Revenues Lag Estimates
-
Collegium Pharmaceutical: Q1 Earnings Snapshot
-
Collegium Reports First Quarter 2024 Financial Results
-
Collegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
-
Collegium (COLL) to Report Q1 Earnings: Here's What to Expect
-
Collegium Pharmaceutical: Q4 Earnings Snapshot
-
Collegium Pharmaceutical: Q4 Earnings Snapshot
-
Collegium Reports Record Fourth Quarter and Full-Year 2023 Financial Results
-
Collegium Pharmaceutical: Q3 Earnings Snapshot
-
Collegium Reports Third Quarter 2023 Financial Results
-
Collegium Pharmaceutical (COLL) Reports Next Week: Wall Street Expects Earnings Growth
-
Collegium Pharmaceutical (COLL) Q2 Earnings Beat Estimates
-
Collegium Pharmaceutical (COLL) Q1 Earnings Meet Estimates
-
Collegium Pharmaceutical: Q1 Earnings Snapshot
-
Collegium Reports First Quarter 2023 Financial Results
-
Collegium Pharmaceutical (COLL) Earnings Expected to Grow: Should You Buy?
-
Collegium Pharmaceutical (COLL) Q4 Earnings and Revenues Beat Estimates
-
Collegium Pharmaceutical: Q4 Earnings Snapshot
-
Collegium Pharmaceutical: Q4 Earnings Snapshot
-
Collegium Reports Fourth Quarter and Full-Year 2022 Financial Results
-
Collegium Pharmaceutical (COLL) Reports Next Week: Wall Street Expects Earnings Growth
-
Collegium Pharmaceutical: Q3 Earnings Snapshot
-
Collegium Pharmaceutical (COLL) Lags Q3 Earnings Estimates
-
Collegium Reports Third Quarter 2022 Financial Results
-
Collegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release